Article
Publicly Available
Frontmatter
Published/Copyright:
March 26, 2025
Published Online: 2025-03-26
©2025 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Editorial
- The evolving role of esophageal surgery – advancements, challenges, and the path forward
- Reviews
- Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy
- Active surveillance in patients with a complete clinical response after neoadjuvant chemoradiotherapy for esophageal- and gastroesophageal junction cancer
- Management of subepithelial esophageal tumors
- What is the best surgical approach for esophageal cancer?
- Immunotherapy as a new perspective for the therapy of esophageal cancer
- Voluminous hiatal hernias – the role of robotic surgery
- Oligometastatic disease – a renaissance for surgery?
Articles in the same Issue
- Frontmatter
- Editorial
- The evolving role of esophageal surgery – advancements, challenges, and the path forward
- Reviews
- Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy
- Active surveillance in patients with a complete clinical response after neoadjuvant chemoradiotherapy for esophageal- and gastroesophageal junction cancer
- Management of subepithelial esophageal tumors
- What is the best surgical approach for esophageal cancer?
- Immunotherapy as a new perspective for the therapy of esophageal cancer
- Voluminous hiatal hernias – the role of robotic surgery
- Oligometastatic disease – a renaissance for surgery?